Clinical trial
Iscar for Supplemental Care in Stage IV Lung Cancer
NCT00079794 · National Center for Complementary and Integrative Health (NCCIH), NIH · Completed
Key facts
| NCT number | NCT00079794 |
|---|---|
| Title | Iscar for Supplemental Care in Stage IV Lung Cancer |
| Official title | Iscar for Supplemental Care in Stage IV Lung Cancer |
| Lead sponsor | National Center for Complementary and Integrative Health (NCCIH), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | Iscar, mistletoe |
| Enrollment | 36 |
| Start date | Sep 1, 2001 |
| Primary completion | Feb 1, 2004 |
| Completion | Feb 1, 2004 |
| First posted | Mar 16, 2004 |
| Last update posted | Jan 25, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: